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Human immunodeficiency virus type 1 (HIV-1) evolved via cross-species transmission of simian immunodeficiency
virus (SIVcpz) from chimpanzees (Pan troglodytes). Chimpanzees, like humans, are susceptible to infection by HIV-
1. However, unlike humans, infected chimpanzees seldom develop immunodeficiency when infected with SIVcpz
or HIV-1. SIVcpz and most strains of HIV-1 require the cell-surface receptor CC chemokine receptor 5 (CCR5) to
infect specific leukocyte subsets, and, subsequent to infection, the level of CCR5 expression influences the amount
of HIV-1 entry and the rate of HIV-1 replication. Evidence that variants in the 5′ cis-regulatory region of CCR5
(5′CCR5) affect disease progression in humans suggests that variation in CCR5 might also influence the response
of chimpanzees to HIV-1/SIVcpz. To determine whether patterns of genetic variation at 5′CCR5 in chimpanzees
are similar to those in humans, we analyzed patterns of DNA sequence variation in 37 wild-born chimpanzees (26
P. t. verus, 9 P. t. troglodytes, and 2 P. t. schweinfurthii), along with previously published 5′CCR5 data from 112
humans and 50 noncoding regions in the human and chimpanzee genomes. These analyses revealed that patterns
of variation in 5′CCR5 differ dramatically between chimpanzees and humans. In chimpanzees, 5′CCR5 was less
diverse than 80% of noncoding regions and was characterized by an excess of rare variants. In humans, 5′CCR5
was more diverse than 90% of noncoding regions and had an excess of common variants. Under a wide range of
demographic histories, these patterns suggest that, whereas human 5′CCR5 has been subject to balancing selection,
chimpanzee 5′CCR5 has been influenced by a selective sweep. This result suggests that chimpanzee 5′CCR5 might
harbor or be linked to functional variants that influence chimpanzee resistance to disease caused by SIVcpz/HIV-1.
Introduction
The gene CC chemokine receptor 5 (CCR5 [MIM
601373]) encodes a cell-surface receptor that is exploited
by the human immunodeficiency virus type 1 (HIV-1) to
gain entry to several types of leukocytes (Alkhatib et al.
1996). Genetic variation in CCR5 has been associated
with susceptibility to HIV-1 infection, possibly by af-
fecting the rate at which HIV-1 enters a leukocyte (Lin
et al. 2002; Ondoa et al. 2002). For example, homo-
zygosity for a 32-bp deletion (i.e., CCR5-D32) of the
ORF of CCR5 prevents the expression of functional
CCR5 receptors on the cell surface and confers nearly
complete resistance to infection by HIV-1 (Dean et al.
1996; Huang et al. 1996). Heterozygosity for CCR5-
D32, as well as polymorphisms in the 5′ cis-regulatory
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region of CCR5 (5′CCR5), has also been associated with
the rate at which individuals infected with HIV-1 pro-
gress to AIDS and death (Liu et al. 1996; Martin et al.
1998; Gonzalez et al. 1999; Cunningham et al. 2000;
Mummidi et al. 2000). The mechanisms by which poly-
morphisms in 5′CCR5 may influence disease progression
are unknown. However, different 5′CCR5 haplotypes
have been associated with varied rates of CCR5 tran-
scription (Mummidi et al. 2000). Furthermore, the ex-
pression level of CCR5 affects the amount of HIV-1 entry
and may affect the postentry efficiency of HIV-1 repli-
cation in peripheral blood mononuclear cells (PBMCs)
(Lin et al. 2002).
The HIV-1 pandemic originated via cross-species trans-
mission of simian immunodeficiency virus (SIVcpz) from
chimpanzee (Pan troglodytes), its natural reservoir (Gao
et al. 1999). As with HIV-1, SIVcpz uses CCR5 to fa-
cilitate entry into leukocytes, but infection of chimpan-
zees in the wild by SIVcpz is infrequent and nonpatho-
genic. Chimpanzees are also susceptible to infection by
HIV-1 (Corbet et al. 2000; Santiago et al. 2002), but,
unlike humans, chimpanzees experimentally infected
with HIV-1 rarely develop immunodeficiency or AIDS-
related illnesses (O’Neil et al. 2000; Ondoa et al. 2002).
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Thus, chimpanzees are largely resistant to disease caused
by SIVcpz/HIV-1. The reasons for this resistance are
unknown, but it appears to result, in part, from the
lesser capacity of chimpanzee PBMCs to support HIV-1
replication after cell entry (Ondoa et al. 2002), an effect
similar to that observed in humans (Lin et al. 2002).
These observations support the hypothesis that the
5′CCR5 region of chimpanzees harbors variants that
influence the resistance of chimpanzees to disease caused
by SIVcpz/HIV-1.
Population-genetics analyses of CCR5 in humans have
revealed striking patterns of variation. For example, Ste-
phens et al. (1998) showed that the CCR5-D32 allele has
likely been driven to high frequency in European popu-
lations by positive natural selection, although probably
not as a result of the fitness effects of HIV-1, which has
entered human populations only recently (Stephens et
al. 1998; Schliekelman et al. 2001; Bamshad et al. 2002;
Galvani and Slatkin 2003; Mecsas et al. 2004). Simi-
larly, Bamshad et al. (2002) showed that levels of genetic
diversity in 5′CCR5 are among the highest in the human
genome and have likely been maintained by balancing
natural selection.
Information about the effects of natural selection on
CCR5 in humans has been helpful in generating new
hypotheses about the relationship between CCR5 vari-
ants and susceptibility to infectious disease (Bamshad
and Wooding 2003). Evidence that balancing natural
selection has maintained two haplotype clusters in
5′CCR5, for instance, has led to the hypothesis that the
polymorphisms distinguishing these clusters may be es-
pecially good candidates for association studies (Bam-
shad et al. 2002). Such insights from population-ge-
netics analyses in humans suggest that similar analyses
in chimpanzees and other primates could be helpful in
understanding the variable susceptibility of chimpan-
zees to infectious disease, especially HIV-1, as well as
in understanding the differences between humans and
chimpanzees. To explore inter- and intraspecific patterns
of variation in 5′CCR5 and their implications for func-
tional differences between humans and chimpanzees, we
analyzed patterns of DNA sequence variation in 37 wild-
born chimpanzees from each of three subspecies of chim-
panzee (P. t. verus, P. t. troglodytes, and P. t. schwein-
furthii) and compared them with patterns previously
described in humans, along with patterns of variation
in 50 noncoding regions of the chimpanzee genome.
Material and Methods
Population Samples
A 1,123-bp segment of the 5′ cis-regulatory region of
CCR5 was sequenced in 37 unrelated, wild-born chim-
panzees: 26 from West Africa (P. t. verus), 9 from Central
Africa (P. t. troglodytes), and 2 from East Africa (P. t.
schweinfurthii). The geographical distribution of these
three subspecies is shown in figure 1. Three bonobos
(Pan paniscus) and one gorilla (Gorilla gorilla gorilla)
were also sequenced. These sequences were compared
with previously reported sequences from 112 humans
(Bamshad et al. 2002), including Africans ( ),np 31
Asians ( ), and Europeans ( ) (see supple-np 57 np 24
mentary data [online only] for details). Nonhuman pri-
mate samples were imported in accordance with the
Convention on International Trade in Endangered Spe-
cies of Wild Fauna and Flora (CITES) under permit
99US013176/9. Informed consent was obtained from all
human subjects.
Patterns of diversity in the 5′CCR5 region in chimpan-
zees and humans were compared with patterns of di-
versity in two other data sets. First, a section of hyper-
variable sequence 1 (HV1) of the mtDNA control region
was sequenced in all chimpanzee samples to confirm sub-
species assignment and to allow comparison with other
studies of diversity in mtDNA. Comparisons were also
performed with data from 50 noncoding regions—each
∼500 bp in length—which were sequenced in 17 chim-
panzees (6 P. t. verus, 5 P. t. troglodytes, 2 P. t. schwein-
furthii, and 4 chimpanzees of unknown subspecies) and
30 humans (10 Africans, 10 Asians, and 10 Europeans)
by Yu et al. (2002, 2003). The chimpanzee population
examined by Yu et al. (2002, 2003) is somewhat smaller
than that examined in our study, but it is similar in com-
position, containing all three chimpanzee subspecies.
Laboratory Methods
The region corresponding to the 5′ cis-regulatory re-
gion of human CCR5—which spans from 2867 to
1745 and for which 1 is the nucleotide immediately
upstream of the translational start site at 1—was PCR
amplified and sequenced on both strands (fig. 2A). This
region includes the 3′ end of exon 1, intron 1, exons 2A
and 2B, and the 5′ end of intron 2 (Mummidi et al.
2000). All of these exons are noncoding. PCR primer
sequences were derived from the human genomic se-
quence (GenBank accession numbers AF031236 and
AF031237). Mitochondrial HV1 of the control region
was PCR amplified as described by Morin et al. (1994).
Sequence-trace files were evaluated using the Phred,
Phrap, and Consed programs (Ewing et al. 1998). Po-
tential heterozygotes were identified using the PolyPhred
program (Nickerson et al. 1997). Polymorphisms were
verified by manual evaluation of the individual sequence
traces. For most polymorphisms, it was possible to evalu-
ate both the forward and the reverse sequences.
Statistical Analysis
Genetic diversity was measured using vW, a measure
of genetic diversity that is based on the number of vari-
able nucleotide positions in a sample (S) (Watterson
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Figure 1 Geographical distributions of chimpanzee subspecies in Africa (redrawn from the article by Gagneux et al. [2001])
1975), and p, a measure of genetic diversity that is based
on the mean pairwise difference (per nucleotide) between
sequences (Tajima 1983).
Tests of evolutionary neutrality were performed using
Tajima’s D statistic, which compares vW with p (Tajima
1989), and by use of Fu’s FS statistic (Fu 1997), which
compares S with the number of haplotypes observed in
a sample. Tajima’s D test was performed using the stan-
dard method, which is to simulate D values under the
assumption that natural selection has been absent (Ta-
jima 1989). To incorporate varying assumptions about
population size change in human and chimpanzee popu-
lations, these simulations were also performed using the
algorithm of Rogers (1995), as recently implemented by
Wooding et al. (2004). This algorithm assumes that a
population increased suddenly from an ancient popula-
tion size (N1) to a larger population size (N0), t genera-
tions ago, at an infinite-sites mutation rate (m).
Haplotypes were inferred using PHASE (version 2.02),
and all haplotypes found had a high level of statistical
support (Stephens and Donnelly 2003). Evolutionary re-
lationships among haplotypes were inferred using the
ARLEQUIN software package and were depicted by
constructing rooted minimum-spanning (MS) networks.
An orangutan was used as an outgroup species to de-
termine the polarity of the character states. Networks
constructed using parsimony and maximum-likelihood
methods had similar topologies. Ambiguities in the MS
network were drawn as reticulations.
Results and Discussion
Variation in the 5′ Cis-Regulatory Region of CCR5
Ten variable nucleotide positions were identified in the
5′CCR5 region of chimpanzees (fig. 2A), and nucleotide
diversity (p) in the 5′CCR5 region in chimpanzees was
(fig. 3). Most previously published0.00062 0.00053
studies have found higher levels of genetic diversity in
chimpanzees than in humans (Deinard and Kidd 1999;
Kaessmann et al. 2001; Stone et al. 2002; Fischer et al.
2004), but the estimated value of p for chimpanzee
5′CCR5 is lower than that of most other chimpanzee
loci, as well as most human loci (fig. 3). Additionally, p
was ∼4-fold lower in chimpanzees than 5′CCR5 in hu-
mans, in spite of the fact that the two major subspecies
of chimpanzee (western and central) are estimated to
have diverged from one another 430,000–650,000 years
ago, on the basis of an analysis of DNA sequence data
from nine unlinked, intergenic regions totaling ∼19,000
Figure 2 CCR5 variation in chimpanzees and humans. A, Schematic drawing (not to scale) of CCR5, including exons (boxes) and introns.
Polymorphisms found in the 5′ cis-regulatory region of CCR5, which spans from 2867 to 1745, are indicated and numbered. Genomic
sequencing revealed 15 and 10 polymorphisms in humans (bottom) and chimpanzees (top), respectively. An excessive number of singletons is
found in chimpanzees (asterisks [*]), whereas humans have more intermediate-frequency variants than expected under neutrality. B, 5′CCR5
haplotypes observed in chimpanzees. Positions are shown relative to the CCR5 translational start site (1). Only positions that are variable in
chimpanzees or that differ between the chimpanzee sequence and the human consensus sequence are shown. Columns at right indicate the
number of times each haplotype was observed in P. t. verus (Ptv), P. t. troglodytes (Ptt), P. t. schweinfurthii (Pts), and the total sample. Hsp
the human consensus sequence. C, Two of the CCR5 mRNA transcripts found in humans. An ArG mutation at 2205 in the splice-acceptor
site of exon 2A eliminates the production of CCR5A in most chimpanzees. This site has reverted to A in some P. t. troglodytes, suggesting that
they have regained the capability to make CCR5A.
Wooding et al.: Natural Selection on Chimpanzee CCR5 295
Figure 3 Nucleotide diversity in chimpanzees and humans. Each pair of bars represents a different locus/region. Data are from Stone et
al. (2002) (for mtDNA), Deinard and Kidd (1999) (for HOXB6), Yu et al. (2002, 2003) (for 50 nc), Kaessmann et al. (1999, 2001) (for
Xq13.3), Stone et al. (2002) (for NRY [noncoding region of the Y chromosome]), and from the present study (5′CCR5). The 5′CCR5 was the
only region for which humans are more diverse than chimpanzees. In addition, whereas diversity at 5′CCR5 in chimpanzees was lower than
that in the 50 noncoding (nc) regions (Yu et al. 2002, 2003), diversity at 5′CCR5 in humans was higher than that in the 50 noncoding regions.
bp (Fischer et al. 2004). Ordinarily, such extended sub-
division is expected to result in disproportionately high
levels of genetic diversity. In contrast, the value of p in
human 5′CCR5 ( ) was substantially0.0023 0.0015
higher than the average p value in the 50 noncoding
regions in humans (0.00088) (Bamshad et al. 2002).
Like the p values, vW values suggested that levels of
diversity in 5′CCR5 are low in chimpanzees. The vW value
in chimpanzees (0.18) was !95% of the values in the 50
noncoding regions in chimpanzees, whereas the vW value
in humans (0.20) was 185% of the values in the ho-
mologous 50 regions in humans. And, as with p values,
5′CCR5 is the only gene region reported to date in which
the vW value is lower in chimpanzees than in humans.
Therefore, like the p values, the vW value suggests that
5′CCR5 diversity in chimpanzees is low, relative to both
5′CCR5 in humans and other loci in chimpanzees.
To determine whether the low p value in 5′CCR5 was
the result of a sampling bias, we examined HV1 of the
mitochondrial genome in the same animals in which we
had resequenced 5′CCR5. The p value for HV1 in our
sample, 0.0844, was slightly higher than the p value
(0.075) that was estimated by Deinard and Kidd (1999)
for HV1 sequences in a chimpanzee sample of similar
size ( ) and composition (i.e., with all three sub-np 41
species represented). If our sample were unusually homo-
geneous, the estimated value of p for HV1 would have
been lower than Deinard and Kidd’s (1999) estimate of
p—not higher, as was observed. This result suggests that
the low level of diversity found in 5′CCR5 in our sample
chimpanzees is not due to sampling bias.
Nine haplotypes were observed in the 5′CCR5 re-
gion of chimpanzees (fig. 2B), one of which accounted
for 175% of sampled chromosomes. Other haplotypes
ranged in frequency from 1.5% to 6.8%. A test using
Fu’s FS statistic (Fu 1997)—which compares the ob-
served number of haplotypes with the number expected,
given S segregating sites—also yielded significant results
( ; ), suggesting that the number ofF p 3.74 P ! .025S
haplotypes is greater than expected, given the observed
vW. Together, these results indicate that not only is di-
versity in 5′CCR5 in chimpanzees lower than expected,
but an excess of rare haplotypes is also present. Both of
these patterns are consistent with the hypothesis that
positive natural selection has acted to reduce diversity
in this region.
An MS network illustrating the mutational steps among
chimpanzee 5′CCR5 haplotypes differed distinctly from
that observed by Bamshad et al. (2002) for human
5′CCR5 (fig. 4). The network relating chimpanzee hap-
lotypes was starlike, with one common haplotype and
several rare haplotypes, whereas the network relating
human haplotypes exhibited two major, divergent clus-
ters, each of which contained two common haplotypes.
Networks with such dissimilar topologies are often as-
sociated with different evolutionary histories. Starlike
networks are often associated with population growth
or positive natural selection, which cause reductions in
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Figure 4 MS networks of haplotypes of 5′CCR5 in chimpanzees (A) and humans (B). Each circle represents a different haplotype, and
the size of each circle is proportional to the relative frequency of the haplotype. For each haplotype, the extent of shading indicates the fraction
of observations in Africans, Asians, Europeans, or different subspecies of chimpanzee. The lines between haplotypes correspond to one nucleotide
substitution, except where the number of nucleotides is indicated in parentheses. Reticulations indicate ambiguous relationships.
genetic diversity and an excess of rare nucleotide vari-
ants. In contrast, networks with common but divergent
haplotypes are more often associated with the effects of
balancing natural selection or population decline, which
cause increases in diversity and excesses of common nu-
cleotide variants (Bamshad and Wooding 2003). Thus,
the different haplotype networks observed in chimpan-
zees and humans could be the result of differences in
population history, in selective pressure, or both.
An important distinction between the effects of popu-
lation history and natural selection is that population
history should affect all loci equally, whereas natural se-
lection should affect only the local genomic region con-
taining the target of selection. Thus, one way to distin-
guish the effects of natural selection on 5′CCR5 from
those of population history is to compare the value of
p for chimpanzee 5′CCR5 with the value of p for mul-
tiple genomic regions. A total of 50 noncoding regions,
each ∼0.5 kb, were sequenced in humans (Yu et al. 2002)
and chimpanzees (Yu et al. 2003). The value of p for
chimpanzee 5′CCR5 was about half the overall diversity
in chimpanzees ( ) and was lower than 40 ofpp 0.0013
the 50 estimated values of p from individual regions in
chimpanzees. In contrast, the estimated value of p at
5′CCR5 in humans was greater than 45 of the 50 esti-
mated values of p from individual regions in humans.
Together, our findings—(1) the relatively low level of
diversity of 5′CCR5 in chimpanzees, relative to both hu-
man 5′CCR5 and the 50 noncoding regions in chim-
panzee, and (2) the relatively high level of diversity in
human 5′CCR5, relative to both chimpanzee 5′CCR5
and the 50 noncoding regions in humans—are consistent
with the hypothesis that different selective pressures have
acted on this locus in chimpanzees and humans. To in-
vestigate this possibility in more detail, we performed
statistical tests of evolutionary neutrality.
Neutrality Tests
The presence of relatively low p and vW values at
5′CCR5 in chimpanzees is consistent with the hypothesis
that either population growth or positive natural selec-
tion has acted to “sweep” old variants out of a popula-
tion (Bamshad and Wooding 2003). However, low di-
versity levels can also occur when mutation rates or
effective population sizes are low. To distinguish these
alternatives, we used a test of Tajima’s D statistic (Tajima
1989), which exploits the fact that p and vW values are
affected differently by natural selection and population
history. For example, positive natural selection and popu-
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Figure 5 CIs for tests of Tajima’s D, estimated for 5′CCR5 in chimpanzees (A) and humans (B). Each CI shows the demographic parameters
for which neutrality could be rejected (red) or not rejected (blue) on the basis of Tajima’s D test. On the axes, N1 is the effective population
size of the ancestral population, t is the time of expansion (in generations), and N0 is the effective population size of the population after
expansion. For example, if it is assumed that the chimpanzee population has a generation time of 20 years, that the ancient population size
was 25,000, and that the population grew 250-fold 100,000 years ago, then , and the hypothesis of neutralitytp 2(100,000/20)/25,000p 0.4
cannot be rejected. For the negative value of Tajima’s D in chimpanzee 5′CCR5, the hypothesis of neutrality is rejected under constant population
size or recent growth but not under ancient growth. In humans, the value of Tajima’s D for 5′CCR5 is positive, and neutrality cannot be rejected
under either constant population size or recent population growth. Neutrality is rejected under older population growth.
lation growth tend to produce excesses of young, low-
frequency variants, compared with variants in a neu-
trally evolving region in a population of constant size.
Because p is more sensitive to these effects, the value of
p is reduced relative to the value of vW, resulting in nega-
tive D values. In contrast, balancing natural selection and
population decrease tends to produce excesses of old,
intermediate-frequency variants, increasing the value of
p relative to vW and resulting in positive D values.
Because Tajima’s D statistic can be affected by both
population history and natural selection, we performed
these tests by using the method of Wooding et al. (2004).
This method uses the standard approach, which is to
generate the theoretical distribution of D by use of co-
alescent simulations (Tajima 1989). However, these simu-
lations are performed for varying population histories,
as described by Rogers and Harpending (1992) and Rog-
ers (1995) (see also Hudson [1990, 2002]).
Several previous studies have reported that patterns of
genetic variation in chimpanzees are consistent with the
hypothesis that population sizes have been constant.
However, more-recent evidence suggests that central and
eastern chimpanzees, but not western chimpanzees, may
have undergone growth (Gagneux et al. 1999; Goldberg
and Ruvolo 1999; Kaessmann et al. 1999; Wooding and
Rogers 2000; Fischer et al. 2004). In contrast, the pre-
ponderance of genetic evidence in humans suggests that
human populations grew rapidly in the Upper Pleisto-
cene (Harpending and Rogers 2000; Excoffier 2002; Tish-
koff and Verrelli 2003). Because of uncertainty about
the population history of chimpanzees and, to a lesser
extent, humans, we performed tests of Tajima’s D sta-
tistic under varying assumptions about population his-
tory, to generate CIs.
CIs around the magnitude and timing of population
expansion revealed that Tajima’s D statistic was sig-
nificantly more negative ( ; ) than ex-Dp 1.73 P ! .01
pected under the assumption of constant population size
or recent growth in chimpanzees (fig. 5). However, under
the assumption of population decline or ancient popula-
tion growth in chimpanzees (i.e., 1375,000 years before
the present [calculated from an effective population size
of 25,000, 20 years per generation, and a time of ex-
pansion {t} of 1.5 generations]), the estimate of D for
5′CCR5 in chimpanzees was not significantly different
than expected. In humans, the opposite pattern was ob-
served. Tajima’s D was significantly more positive than
expected ( ) under the assumption of ancientDp 0.82
population growth but not under the assumption that
human population size has been constant or has grown
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very recently (fig. 5). Importantly, when D values in both
species differed significantly from expectation, D was
significantly greater than expected in 5′CCR5 in humans
but was significantly less than expected in chimpanzees.
Given evidence that human populations increased in the
Upper Pleistocene, whereas chimpanzee populations have
likely remained nearly constant, the high value of Ta-
jima’s D in humans is most consistent with the effects
of balancing natural selection, whereas the low value of
D in chimpanzees is better explained by recent positive
selection.
Variation in population history between chimpanzee
subspecies is also of potential importance. Evidence from
earlier studies suggests that western chimpanzees (P. t.
verus), in contrast to central chimpanzees (P. t. troglo-
dytes), do not exhibit a high proportion of rare alleles,
relative to the expectations of the standard neutral model;
the mean value of Tajima’s D, estimated from intergenic
DNA segments, is ∼0 (Yu et al. 2003; Fischer et al. 2004).
This pattern is reversed in 5′CCR5. Two of the only three
5′CCR5 haplotypes in western chimpanzees were rare,
and Tajima’s D for 5′CCR5 in western chimpanzees was
more negative ( ; ) than the value ofDp 1.26 P ! .075
D in central chimpanzees ( ; ). Ad-Dp 0.28 P ! .25
ditionally, the value of p in 5′CCR5 of western chim-
panzees (0.00022) was ∼4-fold lower than the value of
p that was estimated from intergenic DNA segments in
western chimpanzees (Fischer et al. 2004). This excess of
rare alleles, albeit in a region of generally reduced nucleo-
tide diversity, is further evidence that 5′CCR5 has been
subject to positive selection. This is especially intriguing
because, although naturally occurring infections have
been found in both central and eastern chimpanzees, no
western chimpanzee infected with SIVcpz has yet been
reported (Santiago et al. 2002). Thus, evidence of a se-
lective sweep on 5′CCR5 appears to be stronger in the
only subspecies of chimpanzee that does not naturally
harbor SIVcpz. This is consistent with the hypothesis
that SIVcpz may have been a source of selective pressure
on 5′CCR5.
To determine whether the value of Tajima’s D statistic
for chimpanzee 5′CCR5 was lower than that for non-
coding regions sampled from throughout the genome—
as would be expected if positive selection has affected
the region—we tested Tajima’s D in chimpanzees from
pooled data from the 50 noncoding autosomal regions
(∼0.5 kb each) sequenced by Yu et al. (2003). This test
revealed that Tajima’s D among noncoding regions was
negative ( ) but not significantly different fromDp 1.2
zero ( ). Other single loci assayed in chimpanzeesP ! .11
have been found to have negative values for Tajima’s D
as well. However, these values have not reached statis-
tical significance, even when relatively large numbers of
chromosomes have been examined (Morin et al. 1994;
Deinard and Kidd 1999; Kaessmann et al. 2001; Stone
et al. 2002). Thus, although there is a trend toward
negative values of Tajima’s D in chimpanzees, the value
of Tajima’s D for 5′CCR5 ( ) is more negativeDp 1.73
than estimates of the average value of Tajima’s D for
individual loci examined to date. Despite evidence of a
genomewide excess of rare alleles in chimpanzees, the
excess of 5′CCR5 alleles is greater than in most regions
of the chimpanzee genome examined to date.
The finding that the signature of a selective sweep in
5′CCR5 varies among chimpanzee subspecies raises ques-
tions as to when the modal 5′CCR5 haplotype origi-
nated, when the sweep may have occurred, and whether
it was limited to or stronger in one subspecies of chim-
panzee. The modal 5′CCR5 haplotype is common in all
three chimpanzee subspecies, suggesting that it origi-
nated prior to the divergence of chimpanzee subspecies.
Alternatively, it could have arisen in one of the chim-
panzee subspecies and spread via migration to other sub-
species, but there is little evidence of gene flow between
subspecies of chimpanzee. Our results also suggest that
the selective sweep occurred only in—or more recently
in—western chimpanzees, even though 5′CCR5 diversity
is reduced in all three chimpanzee subspecies. It is pos-
sible that the sweep occurred prior to the divergence of
all chimpanzee subspecies, but, given that these subspe-
cies diverged from one another ∼500,000 years ago, it
is expected that the signature of a sweep would have
been erased.
Possible Targets of a Selective Sweep
Collectively, patterns of population genetic variation
in 5′CCR5 suggest that this region has been subjected
to a selective sweep in chimpanzees. The biological sig-
nificance of these findings remains to be explored. One
reasonable hypothesis is that the modal 5′CCR5 hap-
lotype in chimpanzees—or a variant in linkage disequi-
librium that has yet to be identified—afforded some pro-
tection against disease caused by SIVcpz and/or other
pathogens, such as poxviruses (Lalani et al. 1999). This
hypothesis is motivated by the observation that the chim-
panzee modal haplotype is most similar to the ancestral
CCR5 human haplotype group A (HHA). Among hu-
man 5′CCR5 haplotypes tested to date, HHA exhibits
the least promoter activity (Mummidi et al. 2000) and
has been associated with delayed progression to AIDS in
African Americans (Gonzalez et al. 1999). Thus, HHA
may retain ancestral characteristics that confer some re-
sistance to AIDS in humans.
The modal haplotype 5′CCR5 in chimpanzees is nearly
fixed in western chimpanzees, and, despite the screening
of several thousand western chimpanzees, none of these
animals has been found to be infected with SIVcpz (San-
tiago et al. 2002). One explanation for the absence of
SIVcpz in western chimpanzees is that the geographic
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separation of this subspecies from other chimpanzee
subspecies predated the emergence of SIVcpz, so west-
ern chimpanzees simply may have not been exposed to
SIVcpz. An alternative explanation that is consistent
with our results is that adaptation has afforded some
resistance to SIVcpz, possibly through evolution of the
5′CCR5 region.
The nature of the selective pressure is unknown, but
one possible target might have been an ArG transition
that abolishes the splice-acceptor site of exon 2A (fig. 2C).
This substitution eliminates the production of CCR5A,
an alternatively spliced transcript of CCR5, but does not
eliminate the production of CCR5B (Mummidi et al.
2000). Whereas A is fixed at this site in humans and all
other apes, this site is a G in 190% of chimpanzee chro-
mosomes we tested, including the chimpanzee modal
haplotype. In addition, the A variant appears to have
been rederived in central chimpanzees from a haplotype
bearing a G (fig. 3). If the G variant were a target of
selection that afforded resistance to SIVcpz, we hypothe-
sized that the A variant might contribute to disease sus-
ceptibility in the small percentage of chimpanzees who—
when experimentally infected with HIV-1—develop im-
munodeficiency or AIDS (O’Neil et al. 2000).
To test the hypothesis that the A variant is more com-
mon in immunocompromised chimpanzees, we sequenced
the 5′CCR5 region of six chimpanzees that became im-
munodeficient after infection with HIV-1. We found that
none of these chimpanzees had the A variant. Indeed,
each of these chimpanzees was instead homozygous for
the modal chimpanzee haplotype. Thus, the inability to
make the CCR5A isoform does not appear, in itself, to
contribute to disease resistance in chimpanzees. How-
ever, the small size of our sample renders this test weak,
and we argue that the A/G substitution merits particular
attention in further efforts to understand HIV-1 disease
and the differences in function, if any, between CCR5A
and CCR5B.
Conclusions
Together, patterns of variation in 5′CCR5 in chimpan-
zees differ appreciably from those in humans. Whereas
variation in 5′CCR5 in humans is dominated by the pres-
ence of two distinct haplotype clusters, variation in chim-
panzees is dominated by a single haplotype. In addition,
whereas levels of diversity at 5′CCR5 in chimpanzees are
low, relative to those found in humans—as well as rel-
ative to those found in 50 noncoding regions of the
chimpanzee genome—levels of diversity at 5′CCR5 in
humans are high, relative to those found in 50 noncoding
regions. Furthermore, whereas the value of Tajima’s D
in humans is significantly greater than expected under
reasonable assumptions about population history and is
thus consistent with the presence of balancing natural
selection, the value of D in chimpanzees is significantly
less than expected under reasonable assumptions about
population history and is thus consistent with the hy-
pothesis that a recent selective sweep has occurred. Al-
though the effects of population history cannot be ruled
out as a partial explanation for our data, the disparate
patterns of variation in humans and chimpanzees suggest
that 5′CCR5 has evolved under appreciably different
historical forces in these two species. The question of
whether the differing patterns of variation at the 5′CCR5
locus in humans and chimpanzees can account for the
disparate susceptibility of these two species to AIDS re-
mains to be explored. More generally, these findings sug-
gest that genetic variants that underlie differences be-
tween human and chimpanzee responses to HIV might
be found by searching for signatures of selection at loci
that influence the pathogenesis of AIDS. Such studies
will be greatly facilitated by access to the complete chim-
panzee genome sequence.
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